Welcome To The Stem Cell Therapeutics HUB On AGORACOM
Stem Cell is a public biotechnology company focused on the development and commercialization of drug-based therapies to treat central nervous system diseases.
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

AGORACOM WIRE - FRIDAY MAY 25TH, 2012

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc.

  • Aim to develop and manufacture the best technology graphite in the world
  • Additional shareholder value will come from investment in commercialized graphene through joint venture partner, Grafoid Inc.

Read More   |   *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

AGORACOM Maintenance Alert: Friday Evening Downtime for About an Hour Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013  Read More   |   *SPONSOR

 

 

Message: Cash

Generic_profile
Rank: [?]
Mail Room
Points: [?]
6
Rating: [?]
Votes: 0
  • Currently 0.0/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Cash

posted on Oct 03, 08 06:00AM

They will be needing to get some cash very soon. Not the best time to do a PP in this market and with the testing currently shut down. Let hope the FDA allow for testing to continue.



Price seems to have stablized.

New Message

Please login to post a reply

AGORACOM Quick Tips

Small & Micro Cap 2.0 Blog by AGORACOM Members Read It Now

President's D.D.

New feature: Hub Presidents can add important links here.